BioLine RX Stock

BioLine RX Documents

Documents

0

Ticker

BLRX.TA

ISIN

IL0011015182

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

BioLine RX SEC Filings

Type
Report
Date
No documents available

BioLine RX Documents 2026

This page contains all official documents and SEC filings for BioLine RX stock (BLRX.TA, ISIN: IL0011015182). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of BioLine RX's regulatory filings.

BioLine RX Stock analysis

BioLine RX BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe.